Citation: D'Angelo AB, Westmoreland DA, Carneiro PB, Johnson J, Grov C. Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?. AIDS Patient Care STDS. 2021 Aug;35(8):327-334. doi: 10.1089/apc.2021.0033. PMID: 34375141; PMCID: PMC8380788.
Authors
Alexa D’Angelo
Project Manager
Drew A. Westmoreland
Assistant Professor, Department of Epidemiology, College of Medicine & College of Public health and Health Professions, University of Florida
Christian Grov
Chair, Community Health and Social Sciences